e-learning
resources
Milan 2017
Sunday, 10.09.2017
Novel pro- and anti-fibrotic mechanisms in pulmonary fibrosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Detrimental role for matrix metalloprotease-1 in the pathogenesis of pulmonary fibrosis
J. Duitman (Paris, France)
Source:
International Congress 2017 – Novel pro- and anti-fibrotic mechanisms in pulmonary fibrosis
Session:
Novel pro- and anti-fibrotic mechanisms in pulmonary fibrosis
Session type:
Thematic Poster
Number:
1034
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Duitman (Paris, France). Detrimental role for matrix metalloprotease-1 in the pathogenesis of pulmonary fibrosis. 1034
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Asbestosis
Whole genome sequencing of the highly virulent subtype B0/W148 of the Beijing genotype M.tuberculosis in Kharkiv, East Ukraine
Related content which might interest you:
Role of matrix metalloproteinases in progression of idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010
A role of matrix metalloproteinases and their inhibitors in the pathogenesis of fibrosis and angiogenesis in lung precancer processes
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010
Tranilast inhibits pulmonary fibrosis by suppressing TGFbeta-mediated extracellular matrix protein production
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Expression of elastolytic matrix metalloproteinases in bleomycin-induced pulmonary fibrosis
Source: Eur Respir J 2002; 20: Suppl. 38, 228s
Year: 2002
Role of endothelin in lung fibrosis
Source: Eur Respir Rev 2008; 17: 145-150
Year: 2008
The prognostic role of matrix metalloproteinase-7 in scleroderma-associated interstitial lung disease
Source: Eur Respir J, 58 (6) 2101560; 10.1183/13993003.01560-2021
Year: 2021
Metalloproteinases in idiopathic pulmonary fibrosis
Source: Eur Respir J 2011; 38: 1461-1467
Year: 2011
Increased endothelial and epithelial apoptosis play a central role in the pathogenesis of systemic sclerosis and idiopathic pulmonary fibrosis
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008
MMP expression and abnormal lung permeability are important determinants of outcome in IPF
Source: Eur Respir J 2009; 33: 77-84
Year: 2009
Low telomerase expression in alveolar epithelial plays a role in the pathogenesis of idiopathic pulmonary fibrosis
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008
Renin is an angiotensin-independent profibrotic mediator: role in pulmonary fibrosis
Source: Eur Respir J 2011; 39: 141-148
Year: 2012
Renin is an angiotensin-independent profibrotic mediator: role in pulmonary fibrosis
Source: Eur Respir J 2012; 39: 141-148
Year: 2012
Matrix metalloproteinase-2 is protective in bleomycin-induced pulmonary fibrosis
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015
The role of chemokines and cytokines in lung fibrosis
Source: Eur Respir Rev 2008; 17: 151-156
Year: 2008
Synergistic role of HSP90a and HSP90ß to promote myofibroblast persistence in lung fibrosis
Source: Eur Respir J, 51 (2) 1700386; 10.1183/13993003.00386-2017
Year: 2018
Increased fibrinolytic mediators in IPF as potential contributors to pulmonary fibrosis and vascular remodeling
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015
Matrix metalloproteinase (MMP)-2 production by fibroblasts and mast cells: the role in pulmonary fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 455s
Year: 2004
Matrix metalloproteinases, as markers of the severity of idiopathic pulmonary fibrosis
Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Year: 2019
Pathogenesis of idiopathic pulmonary fibrosis: role of neutrophil inflammation
Source: Eur Respir J 2006; 28: Suppl. 50, 102s
Year: 2006
The role of viruses in the pathogenesis of pulmonary fibrosis
Source: Virtual Congress 2021 – Viral infections trigger chronic lung damage and disease
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept